Age-Related Macular Degeneration
Age-related macular degeneration is controlled by antiangiogenic gene therapy
Published in Gene Therapy Weekly, October 5th, 2006
"Choroidal neovascularization (CNV) is the leading cause of blindness in AMD. Several lines of evidence implicate increased levels of vascular endothelial growth factor (VEGF) in retinal pigment epithelium (RPE) from patients with AMD," scientists in the United States report.
"Current approaches to attenuate VEGF or its receptors, including the use of small interfering (si) RNA, show significant promise but still have limited efficacy and require repeat administrations, using procedures associated with multiple complications. The goal of this study was to develop...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-10-05)
More Articles from Gene Therapy Weekly
- Cancer Therapy
Combination rapamycin-chemotherapy sensitivity and resistance determined - Genetics & Genomics
Specific domains required for origin recognition complex nuclear localization - Glioma
Malignant glioma DNA silencing targets revealed by epigenomic profiling - RNA Interference
Caenorhabditis elegans RNA interference requires ATP-binding cassette transporters - AAT Deficiency
Extensive post-license data reaffirm clinical safety profile of Prolastin - Adipogenesis
Increased triplet repeat-binding protein predisposes to impaired adipogenesis - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
